Top Medical Bulletin 30/June/2022

Here are the top medical stories for today:

Pollution exposure associated with multimorbidity risk

Exposure to the air pollution known as fine particulate matter (PM2.5) is associated with an increased risk of having a cluster of multiple chronic diseases, according to a new study published this week in the open-access journal PLOS Global Public Health.

In the new study, the researchers used data on 19,098 respondents of the China Health and Retirement Longitudinal Study (CHARLS) surveys from 2011 to 2015, as well as historical satellite data on PM2.5 exposure over 15 years. Participants were people aged 45 to 85 from 125 cities across China.

For more details, check out the full story on the link below:

Pollution exposure can cause multimorbidity risk 

Study finds women have more brain changes after menopause

Women who have gone through menopause may have more of a brain biomarker called white matter hyperintensities than premenopausal women or men of the same age, according to a new study published in the June 29, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

For more details, check out the full story on the link below:

Women to have more brain changes after menopause 

Children conceived via infertility treatments and education and mental health outcomes

Children conceived through medically assisted reproduction (MAR) fare better at school but are slightly more likely to have mental health problems by their late teens, finds a new study.

Published in the European Journal of Population, the observational study explores the link between medically assisted reproduction - including techniques such as IVF treatment, artificial insemination and ovulation induction - and young people's educational outcomes and mental health.

For more details, check out the full story on the link below:

Children conceived via infertility treatments to have low mental health outcomes

Rivaroxaban effective in treating VTE in symptomatic peripheral artery disease after lower extremity revascularization 

A new cohort study found that 6564 patients undergoing lower extremity revascularization for peripheral arterial disease, the 3-year rate of venous thromboembolism (VTE) in patients receiving placebo was 1.66%, and low-dose rivaroxaban plus aspirin was associated with reduced risk for venous thromboembolism.

For more details, check out the full story on the link below:

Rivaroxaban effective in treating VTE in symptomatic peripheral artery disease after lower extremity